The Latest Cardiac and Vascular News
CLICHY, France–(BUSINESS WIRE)–CorWave, a French company that develops and manufactures innovative cardiac assist devices, announces the appointment of Fairuz Hasni as Vice President Human Resources. Fairuz Hasni has over twenty years of experience in industrial companies. She will support CorWave […]
CLICHY, France–(BUSINESS WIRE)–CorWave, a French company that develops and manufactures innovative cardiac assist devices, held the grand opening of its new facility on the banks of the Seine in Clichy, next to Paris, on Monday, October 9th. The company occupies […]
CLICHY, France–(BUSINESS WIRE)–CorWave raised 61 million euros to fund its first industrial deployment and entry into clinical trials. SPI fund, managed by Bpifrance on behalf of the French Government as part of France 2030, and leading family controlled entrepreneurial groups […]
CLICHY, France–(BUSINESS WIRE)–The medtech company CorWave is taking a new step in its development. Already located in Clichy, next to Paris, the industrial start-up is preparing to move to larger premises capable of hosting its R&D center and the manufacturing […]
CLICHY, France–(BUSINESS WIRE)–CorWave, a French medtech developing a next-generation heart pump, is recruiting top talent from throughout the world to strengthen its team. Two seasoned industry experts are joining the company: Paul Cornelison (USA) as Vice President, Regulatory Affairs, Quality […]
PARIS–(BUSINESS WIRE)–CorWave, a French medical device company committed to the fight against heart failure, announced that it has successfully completed the first 90-day preclinical study to evaluate its left ventricular assist device (LVAD) operating synchronously with the native heart without […]
CLICHY, France–(BUSINESS WIRE)–CorWave, a French medical device company committed to the fight against heart failure, unveiled an unprecedented study on the performance of its implantable heart pump at the 41st Annual Meeting of the International Society for Heart and Lung […]
CLICHY, France–(BUSINESS WIRE)–CorWave reported today it has raised $40M from returning investors and three new investors. The company is developing an implantable heart pump (Left Ventricular Assist Device, LVAD) based on a breakthrough technology: the wave membrane pump. These new funds will […]
The presentation was selected as Top Bioengineering Abstract and confirms CorWave’s commitment to scientific excellence, which enabled demonstration of its Left Ventricular Assist Device’s (LVAD) capability to provide durable, long-term circulatory support with high-fidelity physiologic flow CLICHY, France–(BUSINESS WIRE)–CorWave announced […]
Medtech industry veteran of two IPOs on the Nasdaq Stock Market (HeartWare, Avedro) CLICHY, France–(BUSINESS WIRE)–CorWave, a medtech company focused on the development of an innovative Left Ventricular Assist Device (LVAD) to treat patients suffering from severe heart failure, announced […]
